Quantcast
Last updated on April 21, 2014 at 9:11 EDT

Latest PeriGen Inc. Stories

2014-02-24 08:29:23

PeriCALM's obstetric nursing content to be built into one Allscripts electronic health record solution to resolve interface issues CRANBURY, N.J., Feb. 24, 2014 /PRNewswire/ -- University Hospitals (UH) in Cleveland, Ohio, one of the nation's leading healthcare systems, will implement PeriGen's PeriCALM(®) patented, FDA-cleared clinical decision support and fetal surveillance solution at two hospitals, UH MacDonald Women's Hospital in Cleveland and UH Geauga Medical Center in Geauga...

2013-04-04 20:21:11

National Institutes of Health validates company's perinatal technology PRINCETON, N.J., April 4, 2013 /PRNewswire/ -- Continuing its strong momentum from better than anticipated earnings in 2012, PeriGen, the global leader in applying real-time clinical decision support to perinatal systems, announced that it received significant industry recognition, raised $6.4 million in funding, achieved record bookings and expanded its senior management team in the first quarter of 2013....

2013-02-14 12:25:24

PRINCETON, N.J., Feb. 14, 2013 /PRNewswire/ -- PeriGen, Inc., the global leader in applying real-time clinical decision support to perinatal systems, announced today that it has appointed Thomas J.Garite MD as Chief Clinical Officer, effective immediately. (Logo: http://photos.prnewswire.com/prnh/20110512/PH01144LOGO ) A specialist in Obstetrics and Gynecology and Maternal-Fetal Medicine, in addition to his work with PeriGen and its clients, Thomas J. Garite, MD, holds three positions...

2013-01-15 12:27:00

PRINCETON, N.J., Jan. 15, 2013 /PRNewswire/ -- PeriGen, Inc., the global leader in applying real-time clinical decision support to perinatal systems, today announced the results of an independent validation study on fetal strip interpretation favorably comparing PeriGen PeriCALM® Patterns software with the findings of three experts from the National Institute of Health (NIH). The FDA-cleared fetal strip interpretation technology is a component of the company's perinatal central...

2012-08-22 06:24:50

PRINCETON, N.J., Aug. 22, 2012 /PRNewswire/ -- PeriGen, Inc., an innovative provider of fetal surveillance systems, today announced that the results of its program to identify women at increased risk of Shoulder Dystocia (SD) with Brachial Plexus Injury (BPI) have been published in the August issue of the American Journal of Obstetrics and Gynecology (AJOG). The published results show that, with the introduction of this program, overall SD rates fell by more than half with no increase in the...

2012-08-15 10:21:51

PRINCETON, N.J., Aug. 15, 2012 /PRNewswire/ -- PeriGen, Inc., an innovative, national provider of fetal surveillance systems, today announced the publication of research on uterine tachysystole in the June issue of the Journal of Maternal-Fetal and Neonatal Medicine, which showed that high contraction rates were common in deliveries with normal blood gases at birth. The study revealed that fetal heart rate decelerations, in response to any level of contractions, and especially during the last...

2012-08-14 06:28:03

PRINCETON, N.J., Aug. 14, 2012 /PRNewswire/ -- PeriGen, Inc., and The George Washington University, the data coordinating center of the Eunice Kennedy Shriver National Institute of Child Health and Human Development's Maternal-Fetal Medicine Units Network, have entered into an agreement to utilize PeriGen's PeriCALM® Patterns(TM) software in connection with a research project entitled: Computerized Interpretation of Intrapartum FHR and Prediction of Neonatal Outcomes. The primary...

2012-06-25 06:28:06

PRINCETON, N.J., June 25, 2012 /PRNewswire/ -- PeriGen, Inc., the leading innovator of fetal surveillance systems, is launching a patient safety campaign designed to inform pregnant women about shoulder dystocia, a serious childbirth complication. The "Start the Conversation" campaign provides pregnant women with a self-assessment tool that helps determine if they have one or more key risk factors for shoulder dystocia and, if so, encourages them to discuss their findings with their...

2012-06-22 06:22:44

PRINCETON, N.J., June 22, 2012 /PRNewswire/ -- PeriGen, Inc., an innovative, national provider of fetal surveillance systems, will introduce its newest and most advanced electronic fetal monitoring system, PeriCALM® Plus(TM), at the Association of Women's Health, Obstetric and Neonatal Nurses (AWHONN) 2012 Annual Convention, being held June 23-28, 2012 in National Harbor, Maryland. (Logo: http://photos.prnewswire.com/prnh/20110512/PH01144LOGO ) The PeriCALM® Plus(TM) suite is the...

2011-05-12 10:59:00

PRINCETON, N.J., May 12, 2011 /PRNewswire/ -- PeriGen, Inc., the only OB-specific risk reduction company to provide solutions which generate quantifiable clinical and financial value, today announced that it received additional patents from the United States Patent Office for the technology surrounding its PeriCALM® Shoulder Screen(TM) solution. The additional patents add to the strength of the Company's intellectual property portfolio of 16 patents and 21 patents-pending,...